Age-related Diseases: a Growing Market

The world’s population aged 65 and older is growing by an unprecedented 800,000 people a month and the global aging trend is expected to continue well into the 21st century. In many countries, the oldest sector (80 and above) is the fastest-growing component of the population.

The range of diseases and chronic conditions associated with aging provides a breadth of attractive investment opportunities.

The AgeChem Fund L.P. currently has $65 million under management and is seeking to invest in companies developing therapeutics targeting age-related diseases. Principally, AgeChem wishes to build a portfolio of Companies developing novel therapeutics to treat metabolic disorders (e.g. diabetes, obesity), cardiovascular diseases, cancers, diseases of the central nervous system (e.g. Alzheimer, Parkinson, insomnia), inflammatory diseases (e.g. rheumatoid arthritis, psoriasis), ophthalmic diseases and numerous other age-related diseases.